Identification and structural characterization of MMP1 and MMP9 as potential targets of curcumin and resveratrol in lung adenocarcinoma

Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer characterized by substantial molecular heterogeneity and limited therapeutic options. Curcumin and resveratrol are naturally occurring bioactive compounds with reported anticancer activities, but their potential molecular targets and mechanisms in LUAD remain incompletely characterized. Objectives This study aimed to systematically identify and characterize potential molecular targets of curcumin and resveratrol in LUAD using an integrated computational framework. Methods Potential targets of curcumin and resveratrol were collected from multiple compound-target databases and integrated with LUAD-associated genes obtained from GeneCards and OMIM. Shared targets were evaluated using protein-protein interaction analysis and network-based prioritization. Transcriptomic and clinical validation was performed using The Cancer Genome Atlas (TCGA)-LUAD dataset, including differential expression, diagnostic performance, survival analysis, mutation profiling, gene set enrichment analysis (GSEA), immune association, immune checkpoint correlation, and co-expression analysis. Structurally prioritized targets were subsequently investigated using molecular docking, interaction profiling, and redocking validation, followed by molecular dynamics and binding free energy analyses. Results The integrated target-screening strategy identified 976 unique targets for curcumin, 6,897 targets for resveratrol, and 3,885 LUAD-associated targets, with 325 common targets between curcumin, resveratrol, and LUAD. Downstream investigation of potential targets identified MMP1 and MMP9 from network and multi-level evidence prioritization. Both genes demonstrated diagnostic potential in TCGA-LUAD, with MMP1 achieving an area under the receiver operating characteristic curve (AUC) of 0.9281 (95% CI: 0.8785-0.9776) and MMP9 an AUC of 0.8466 (95% CI: 0.7727–0.9205). However, MMP1 and MMP9 were not independently related to overall survival in stage-adjusted survival analysis models. Functional enrichment analysis identified biological pathways associated with the expression profiles of MMP1 and MMP9, while immune cells, immune checkpoint, and gene co-expression analyses indicated broader molecular and immune associations. Molecular docking demonstrated favorable predicted binding of curcumin and resveratrol to MMP1 and MMP9, with docking scores ranging from −7.0 to −9.9 kcal/mol. Mutation analysis further identified an MMP1 p.R214S variant at a residue corresponding to ARG214 involved in the predicted resveratrol interaction, suggesting a potentially relevant structural association. Molecular dynamics and MM/GBSA analysis showed that the selected complexes are stable and energetically favorable. DFT calculation indicated different electronic properties of both the compounds, ADMET analysis demonstrated good drug like properties for both compounds, complying the Lipinski’s Rule of Five. Conclusion Overall, this integrated computational analysis identified MMP1, and MMP9 as potential molecular targets associated with curcumin and resveratrol in LUAD. The combined structural, dynamic, electronic, pharmacokinetic, and toxicity evaluations provide a comprehensive framework for prioritizing these compounds and targets for further experimental investigation.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-19
DOI
https://doi.org/10.1371/journal.pone.0362473
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification and structural characterization of MMP1 and MMP9 as potential targets of curcumin and resveratrol in lung adenocarcinoma

Jarin Tasnim, Md. Ekhlas Uddin, Md. Ramjan Sheikh, Apu Chakraborty et al.
PLoS ONE
Computational Drug Discovery Methods
article

Identification and structural characterization of MMP1 and MMP9 as potential targets of curcumin and resveratrol in lung adenocarcinoma

Jarin Tasnim, Md. Ekhlas Uddin, Md. Ramjan Sheikh, Apu Chakraborty, Md. Muntasir Alam Muhib, Md. Abu Sayed Parvez, Asmia Iqbal, Md. Tanvir Ahmed, Protoy Nandi, S. M. Emran Ali
article en

Abstract

Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer characterized by substantial molecular heterogeneity and limited therapeutic options. Curcumin and resveratrol are naturally occurring bioactive compounds with reported anticancer activities, but their potential molecular targets and mechanisms in LUAD remain incompletely characterized. Objectives This study aimed to systematically identify and characterize potential molecular targets of curcumin and resveratrol in LUAD using an integrated computational framework. Methods Potential targets of curcumin and resveratrol were collected from multiple compound-target databases and integrated with LUAD-associated genes obtained from GeneCards and OMIM. Shared targets were evaluated using protein-protein interaction analysis and network-based prioritization. Transcriptomic and clinical validation was performed using The Cancer Genome Atlas (TCGA)-LUAD dataset, including differential expression, diagnostic performance, survival analysis, mutation profiling, gene set enrichment analysis (GSEA), immune association, immune checkpoint correlation, and co-expression analysis. Structurally prioritized targets were subsequently investigated using molecular docking, interaction profiling, and redocking validation, followed by molecular dynamics and binding free energy analyses. Results The integrated target-screening strategy identified 976 unique targets for curcumin, 6,897 targets for resveratrol, and 3,885 LUAD-associated targets, with 325 common targets between curcumin, resveratrol, and LUAD. Downstream investigation of potential targets identified MMP1 and MMP9 from network and multi-level evidence prioritization. Both genes demonstrated diagnostic potential in TCGA-LUAD, with MMP1 achieving an area under the receiver operating characteristic curve (AUC) of 0.9281 (95% CI: 0.8785-0.9776) and MMP9 an AUC of 0.8466 (95% CI: 0.7727–0.9205). However, MMP1 and MMP9 were not independently related to overall survival in stage-adjusted survival analysis models. Functional enrichment analysis identified biological pathways associated with the expression profiles of MMP1 and MMP9, while immune cells, immune checkpoint, and gene co-expression analyses indicated broader molecular and immune associations. Molecular docking demonstrated favorable predicted binding of curcumin and resveratrol to MMP1 and MMP9, with docking scores ranging from −7.0 to −9.9 kcal/mol. Mutation analysis further identified an MMP1 p.R214S variant at a residue corresponding to ARG214 involved in the predicted resveratrol interaction, suggesting a potentially relevant structural association. Molecular dynamics and MM/GBSA analysis showed that the selected complexes are stable and energetically favorable. DFT calculation indicated different electronic properties of both the compounds, ADMET analysis demonstrated good drug like properties for both compounds, complying the Lipinski’s Rule of Five. Conclusion Overall, this integrated computational analysis identified MMP1, and MMP9 as potential molecular targets associated with curcumin and resveratrol in LUAD. The combined structural, dynamic, electronic, pharmacokinetic, and toxicity evaluations provide a comprehensive framework for prioritizing these compounds and targets for further experimental investigation.

PLoS ONEVol. 21(11)
Shahjalal University of Science and Technology (BD), North South University (BD), Daffodil International University (BD), Pabna University of Science and Technology (BD), National University Bangladesh (BD), Independent University, Bangladesh (BD), Gono University (BD), University of Rajshahi (BD)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon